Covered recipient · General Payments record
CECILY D HAVERT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,223.94
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $815.58 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $206.48 | 9 |
| Amgen Inc. | $179.29 | 8 |
| PFIZER INC. | $105.56 | 5 |
| ABBVIE INC. | $90.44 | 4 |
| Lilly USA, LLC | $82.77 | 4 |
| Acerta Pharma LLC | $58.27 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $42.94 | 2 |
| Exact Sciences Corporation | $33.32 | 1 |
| Medtronic, Inc. | $16.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.83 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103893219 | CMS |
| ABBVIE INC. | $17.82 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103893221 | CMS |
| ABBVIE INC. | $30.39 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103893223 | CMS |
| ABBVIE INC. | $24.40 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103893225 | CMS |
| Amgen Inc. | $27.33 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273787 | CMS |
| Amgen Inc. | $22.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596182 | CMS |
| Amgen Inc. | $23.55 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596184 | CMS |
| Amgen Inc. | $31.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273789 | CMS |
| Amgen Inc. | $25.24 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596186 | CMS |
| Amgen Inc. | $6.87 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596190 | CMS |
| Amgen Inc. | $20.74 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596188 | CMS |
| Amgen Inc. | $20.80 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596192 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105483839 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.48 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104604890 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.97 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105694312 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.98 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109778 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $25.96 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086214659 | CMS |
| Exact Sciences Corporation | $33.32 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114696126 | CMS |
| Lilly USA, LLC | $21.84 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136109038 | CMS |
| Lilly USA, LLC | $20.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136094329 | CMS |
| Lilly USA, LLC | $21.69 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136094327 | CMS |
| Lilly USA, LLC | $19.18 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136092914 | CMS |
| Medtronic, Inc. | $16.51 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119446173 | CMS |
| Novo Nordisk Inc | $22.03 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097334336 | CMS |
| Novo Nordisk Inc | $16.13 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097063442 | CMS |
| Novo Nordisk Inc | $11.91 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097532451 | CMS |
| Novo Nordisk Inc | $25.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097329447 | CMS |
| Novo Nordisk Inc | $23.32 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096710873 | CMS |
| Novo Nordisk Inc | $27.18 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096738579 | CMS |
| Novo Nordisk Inc | $34.81 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097380875 | CMS |
| Novo Nordisk Inc | $26.90 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096835644 | CMS |
| Novo Nordisk Inc | $19.20 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096662805 | CMS |
| PFIZER INC. | $16.42 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131716804 | CMS |
| PFIZER INC. | $24.09 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131726242 | CMS |
| PFIZER INC. | $22.27 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132079055 | CMS |
| PFIZER INC. | $20.82 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131122036 | CMS |
| PFIZER INC. | $21.96 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131021526 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.